In the present study, we used MUC4 antibodies (anti-MUC4) labeled with IRDye800CW to brightly target human pancreatic cancer liver metastases and peritoneal carcinomatosis in nude mouse models. This evidence concerns the gene MUC4 and pancreatic neoplasm.